News
COVID-19, Pfizer and Moderna
Pfizer, BioNTech Get CHMP Backing for Updated Covid-19 Vaccine
Pfizer and BioNTech said a key European regulatory committee recommended approval of an updated version of their updated Comirnaty Covid-19 vaccine that targets the LP.8.1 strain. The companies on Friday said the recommendation by the European Medicines Agency's Committee for Medicinal Products for Human Use covers the LP.
The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children ...
Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the ...
Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...
The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...
The Moderna Covid-19 vaccine received full approval from the U.S. Food and Drug administration Monday, 11 months after the shot was given an emergency use authorization.
Moderna has full FDA approval for its COVID-19 vaccine, which is marketed under the brand name Spikevax. It’s already been administered for a year under an emergency authorization.
The FDA granted full approval to Moderna’s Covid-19 vaccine on Monday, making it the country’s second fully licensed vaccine to protect against SARS-CoV-2.
Moderna COVID-19 Vaccine Awaits FDA Approval. What Is Known About The Drugmaker? NPR's Audie Cornish speaks with Peter Loftus of The Wall Street Journal about Moderna's history and the fact that ...
Stocktwits on MSN15d
Moderna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And OlderModerna, Inc. (MRNA) on Thursday announced that the U.S. Food and Drug Administration (FDA) has fully approved its COVID-19 vaccine Spikevax in children aged six months through 11 years who are at ...
Moderna has completed its submission to the US Food and Drug Administration seeking full approval for its COVID-19 vaccine for those aged over 18, the company announced Wednesday.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results